CytomX Therapeutics (NasdaqGS:CTMX) FY Conference Transcript
CytomX Therapeutics (NasdaqGS:CTMX) FY Conference September 09, 2025 11:30 AM ET Company ParticipantsSean McCarthy - CEOConference Call ParticipantsJade Montgomery - AnalystJade MontgomeryGood afternoon, everyone, and thank you for joining the 2025 H.C. Wainwright 27th Annual Global Investment Conference. I'm Dr. Jade Montgomery, an Associate Biotech Research Analyst at the firm, and I'd like you to please join me in welcoming Dr. Sean McCarthy, CEO of CytomX Therapeutics. Sean?Sean McCarthyThank you, Jade, ...